June 8, 2010 – Sorin Group, (Reuters Code: SORN.MI), a global company and a leader in the treatment of cardiovascular diseases, announced that it has acquired Gish Biomedical from Ventizz Capital Partners, a private equity group focused on technology-oriented companies.
Based in California, Gish Biomedical designs and manufactures disposable medical devices for cardiovascular surgery, with a focus on the Perfusionist. Gish products have been marketed both in the United States and worldwide for over 25 years... Sorin Group's Press Release - [PDF] GISH Biomedical's Press Release -
